Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0016199 (
flank pain
)
2,189
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A 73-year-old man was admitted to the hospital complaining of gross hematuria and left
flank pain
. Abdominal ultrasonography and computed tomography revealed a left renal tumor with extracapsular extension. Laboratory data showed marked leukocytosis of 121,000/mm3 and hypercalcemia of 12.3 mg/dl without any findings of inflammatory disease or bone metastasis. Enzyme immunoassay of the serum demonstrated a high level of
granulocyte colony-stimulating factor
(250 pg/ml) and parathyroid hormone-related protein (1,069 pmol/l). Pathological diagnosis of needle biopsy specimen of the primary tumor was transitional cell carcinoma which was suspected to have originated from renal pelvis. Immunohistochemical examination with anti-
granulocyte colony-stimulating factor
monoclonal antibody demonstrated
granulocyte colony-stimulating factor
production in cancer cells. The patient underwent a course of systemic chemotherapy, but died two months after diagnosis. To our knowledge, this is the first report of renal pelvic cancer representing
granulocyte colony-stimulating factor
production and hypercalcemia simultaneously.
...
PMID:[Renal pelvic cancer representing G-CSF production and hypercalcemia simultaneously: a case report]. 1199 9
We present the first case report of the use of sorafenib and S-1 for the treatment of renal cell carcinoma (RCC) producing
granulocyte colony-stimulating factor
(
G-CSF
). This entity is clinically rare and has a poor outcome. A 78-year-old Japanese man presented with macrohematuria, left
flank pain
, and a palpable mass. Laboratory data showed marked leukocytosis with increased serum and urinary
G-CSF
. The histopathological diagnosis was unclassified RCC. New combination therapy with sorafenib and S-1 exerted a therapeutic effect and apparently decreased serum and urinary
G-CSF
levels, although the patient died of gastrointestinal perforation. The use of combined sorafenib and S-1 may be worthy of consideration in the treatment of RCC producing
G-CSF
.
...
PMID:Combination therapy with sorafenib and S-1 for renal cell carcinoma producing granulocyte colony-stimulating factor. 2084 54
Our patient was a 31-year-old man who presented with right
flank pain
. Computed tomography revealed multiple tumors in the liver and lungs, with marked elevation of serum human chorionic gonadotropin (HCG) and alpha-fetoprotein (AFP) levels. In addition, no testicular abnormalities were detected by palpation or ultrasonography. On the bases of these results, the patient was diagnosed with extragonadal germ cell tumor and was therefore started on chemotherapy with bleomycin, etoposide, and cisplatin (BEP). However, the result of a subsequent blood test showed marked pancytopenia at the initial stage of treatment. We speculated that the cause of anemia was not only bone marrow suppression but also intratumoral hemorrhage, collectively termed choriocarcinoma syndrome. After conservative treatment involving blood transfusion and administration of
granulocyte colony-stimulating factor
, he recovered. After several chemotherapy sessions, the levels of all tumor markers returned to normal. Finally, the patient underwent hepatectomy for residual tumors ; but, the resected specimen showed no viable cancer cells. Currently, the patient is free from disease since the last chemotherapy session, administered 5 months ago.
...
PMID:[A suspected case of extra-gonadal germ cell tumor complicated with choriocarcinoma syndrome]. 2371 41